1. DOP018 Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn's disease. (16th January 2018) Authors: Creyns, B; Verstockt, B; Cremer, J; Ferrante, M; Vermeire, S; Jan, C; Van Assche, G; Breynaert, C Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗